Should one stop taking Ibrutinib if receiving Sotrovimab or Paxlovid for COVID?
Just a precautionary question.
Should one stop taking Ibrutinib if receiving Sotrovimab or Paxlovid for COVID?
Just a precautionary question.
Check with physician.
Listed drug interactions Sotrovimab webmd.com//drugs/2/drug-181... and Paxlovid webmd.com/drugs/2/drug-1832...
Hi RobertCLL,
-
We have had several recent discussions about the interaction of Paxlovid. The bottom line is that Paxlovid is taken for 5 days, and during those days only (no pause before or after) your doctor should modify your dose to reduce or pause taking Ibrutinib.
-
See healthunlocked.com/cllsuppo...
-
Len
Does this also apply to Venetoclax? It would appear so from the drug interactions reference cited?
Yes,
-
It applies to all the CLL drugs that have a "grapefruit" warning ( to avoid CYP3A inhibitors). Paxlovid will cause those drugs to act much stronger and stay in your blood much longer, possibly making side effects worse.
-
Len
Many thanks for such a quick reply. I am hoping not to require any of these measures as I am living like a hermit whilst going through first line O& V treatment but better to know just in case so it looks as if it would be sotrovimab for me or a pause in Venetoclax if doctor advises. Think I will maintain my undercover status till treatment is over.
Hi Sumoldbloke,
-
There seems to be some indications that the latest sub variant can overcome sotrovimab, so Dr. Furman is recommending Paxlovid for COVID positive / exposed patients and Evusheld as preventive / prophylactic. -
Len
Many thanks for the replies. Just spoken to my GP, and having my recorded amended to state that Paxlovid is contraindicated for me. Therefore, Sotrovimab should be administered.
As I said just a precautionary activity, just in case.